Inpatient Workup for Hypercalcemia
The initial inpatient workup for hypercalcemia requires immediate measurement of serum calcium (corrected for albumin or ionized calcium), intact parathyroid hormone (PTH), and assessment of severity to guide urgent management decisions. 1
Immediate Laboratory Assessment
Essential First-Line Tests
- Serum calcium: Measure total calcium corrected for albumin OR ionized calcium directly
- Intact PTH: This single test distinguishes PTH-dependent from PTH-independent causes 2
- Elevated or normal PTH = primary hyperparathyroidism or familial hypocalciuric hypercalcemia
- Suppressed PTH (<20 pg/mL) = malignancy, medications, granulomatous disease, or other non-PTH mediated causes
Severity Stratification (Critical for Management)
- Mild: Serum calcium <12 mg/dL (<3 mmol/L)
- Moderate: 12-14 mg/dL (3-3.5 mmol/L)
- Severe: >14 mg/dL (>3.5 mmol/L) 1
Algorithmic Diagnostic Approach
If PTH is Suppressed (Non-PTH Mediated)
Screen for malignancy (accounts for ~45% of all hypercalcemia cases):
- Review cancer history
- PTHrP (parathyroid hormone-related peptide) if solid tumor suspected
- Serum protein electrophoresis/immunofixation for multiple myeloma
- Consider imaging (chest X-ray, CT) based on clinical suspicion
Measure 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D (calcitriol):
- Elevated calcitriol suggests granulomatous disease (sarcoidosis, tuberculosis) or lymphoma 1
- Elevated 25-hydroxyvitamin D suggests vitamin D intoxication
Medication review (discontinue potential culprits):
- Thiazide diuretics
- Lithium
- Calcium and vitamin D supplements
- Vitamin A
- Consider recent denosumab discontinuation 2
If PTH is Elevated or Normal (PTH-Mediated)
Primary hyperparathyroidism workup:
- 24-hour urine calcium (to exclude familial hypocalciuric hypercalcemia)
- Renal function (creatinine, eGFR)
- Bone density scan (DEXA) if considering observation vs surgery
- Renal ultrasound or CT (assess for nephrolithiasis/nephrocalcinosis)
Consider parathyroid imaging only if surgery is planned:
- Sestamibi scan
- Neck ultrasound
Additional Context-Dependent Tests
For Suspected Malignancy-Related Hypercalcemia
- Complete blood count
- Comprehensive metabolic panel (assess renal function—critical for treatment decisions)
- Alkaline phosphatase (bone involvement)
- Imaging as clinically indicated
For Suspected Granulomatous Disease
- Chest imaging
- ACE level (sarcoidosis)
- Consider tissue biopsy
Critical Clinical Pitfalls to Avoid
Do not delay PTH measurement: This is the single most important test and should be drawn before initiating treatment when possible 3, 4
Correct calcium for albumin: Use ionized calcium if albumin is abnormal or in critically ill patients to avoid misdiagnosis
Do not assume primary hyperparathyroidism in hospitalized patients: Malignancy is more common in the inpatient setting, especially with moderate-to-severe hypercalcemia 1
Assess rapidity of onset: Acute hypercalcemia (days to weeks) is more likely malignancy-related and more symptomatic even at lower calcium levels 1
Check medications thoroughly: Thiazides, lithium, and excessive calcium/vitamin D supplementation are frequently overlooked iatrogenic causes 2
Symptom Assessment (Guides Urgency)
Document presence of:
- Neurologic: Confusion, lethargy, somnolence, coma
- Gastrointestinal: Nausea, vomiting, constipation, abdominal pain
- Renal: Polyuria, polydipsia, dehydration
- Cardiovascular: Shortened QT interval on ECG
- Constitutional: Fatigue, weakness
Severe symptoms or calcium >14 mg/dL require immediate aggressive treatment with IV hydration and antiresorptive therapy (IV bisphosphonates or denosumab) while completing the diagnostic workup 1.